Abstract
CRISPR-Cas9 technology has rapidly emerged as a powerful and precise tool in molecular biology, offering unprecedented potential across diverse applications, including gene therapy, agricultural enhancement, and disease prevention. This review examines the molecular mechanisms of CRISPR-Cas9, its ethical considerations, and the current regulatory landscape governing its use. By exploring case studies and highlighting future perspectives, the paper underscores the ethical challenges associated with human germline editing, ecological risks in agriculture, and the societal implications of accessible gene-editing technology. As CRISPR-Cas9 advances, responsible regulation and ethical frameworks are essential to balance its scientific promise with potential risks. The review concludes by emphasizing the importance of global collaboration and public engagement in shaping the responsible and equitable use of CRISPR-Cas9 to foster societal benefit while addressing ethical concerns.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 African Journal of Biomedical Research